EPCAM and ovarian carcinoma: Previous studies have utilized multiantibody-modified magnetic nanoparticles targeting MSLN, EpCAM, and N-cadherin for the isolation and molecular analysis of circulating tumor cells in epithelial ovarian cancer (36).